Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients
Int. Journal of Clinical Pharmacology and Therapeutics · 10.09.2026
DOI: 10.5414/cp204936 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 10.09.2026. Verfasst von Lingyan Kong und 1 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kong, L., & Gu, X. (2026). Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204936
Vancouver
Kong L, Gu X. Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients. Int. Journal of Clinical Pharmacology and Therapeutics. 2026. doi:10.5414/cp204936
BibTeX
@article{Kong2026,
author = {Kong, Lingyan and Gu, Xuechun},
title = {Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
doi = {10.5414/cp204936}
}
EUVIMED